Telacebec Interferes with Virulence Lipid Biosynthesis Protein Expression and Sensitizes to Other Antibiotics
Tuberculosis (TB), caused by <i>Mycobacterium tuberculosis</i> (Mtb), remains a public health issue, particularly due to multi-drug-resistant Mtb. The bacillus is wrapped in a waxy envelope containing lipids acting as essential virulence factors, accounting for the natural antibiotic res...
Main Authors: | Zhiyu Zhou, Ruddy Wattiez, Patricia Constant, Hedia Marrakchi, Karine Soetaert, Vanessa Mathys, Véronique Fontaine, Sheng Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/11/10/2469 |
Similar Items
-
Novel modeling approach integrating population pharmacokinetics and interspecies scaling to predict human pharmacokinetics of the new anti-tuberculosis agent telacebec (Q203)
by: Jeongjun Kim, et al.
Published: (2023-11-01) -
Time to face the proofs: the BCG Moreau vaccine promotes superior inflammatory cytokine profile in vitro when compared with Russia, Pasteur, and Danish strains
by: Andreon Santos Machado da Silva, et al.
Published: (2022-01-01) -
Protective Efficacy of BCG Vaccination in Calves Vaccinated at Different Ages
by: Jayne C. Hope, et al.
Published: (2023-05-01) -
TUBERCULOSE DE ARCO COSTAL EM LACTENTE: UM RELATO DE CASO
by: Alexia Lavínia Holanda Gama, et al.
Published: (2023-10-01) -
[Fever of Unknown Origin in a Patient Administered With Bacillus Calmette-Guérin (BCG) to Treat Urothelial Vesical Carcinoma in Situ]
by: Paolo Ghiringhelli, et al.
Published: (2023-07-01)